Video Experimental Relacionado
Updated: Sep 10, 2025
12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.9K
Sistemas de administración de fármacos dirigidos en el tratamiento del linfoma: avances y perspectivas clínicas
Qianqian Guo1, Yingshu Luo2, Xin Wang3
1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
Biochimica et biophysica acta. Reviews on cancer
|August 23, 2025
Resumen
Los nuevos sistemas de administración de medicamentos son prometedores para mejorar la eficacia y la orientación del tratamiento del linfoma. Estos sistemas avanzados tienen como objetivo superar las limitaciones de las terapias actuales, mejorando potencialmente los resultados para los pacientes con enfermedad recurrente o refractaria.
Área de la Ciencia:
- Oncología hematológica
- La nanomedicina
- Sistemas de administración de fármacos
Sus antecedentes:
- Los linfomas son cánceres sanguíneos complejos con resistencia al tratamiento en aproximadamente el 30% de los pacientes.
- Las terapias actuales se enfrentan a limitaciones en la eficacia y la orientación, lo que lleva a la recurrencia de la enfermedad y la mortalidad.
- Los avances en los sistemas de administración de medicamentos ofrecen nuevas vías para mejorar los resultados del tratamiento del linfoma.
Objetivo del estudio:
- Revisar los diversos sistemas de administración de fármacos utilizados en el tratamiento del linfoma.
- Destacar las aplicaciones actuales y el potencial futuro de estos sistemas específicos.
- Explorar cómo los nuevos métodos de administración pueden mejorar la eficacia terapéutica y reducir la toxicidad.
Principales métodos:
- Revisión de la literatura de varios sistemas de administración de medicamentos para el linfoma.
- Análisis de nanotransportadores, proteínas, aptameros y exosomas en la terapia dirigida.
- Examen de las estrategias de incorporación y conjugación de fármacos para mejorar la administración.
Principales resultados:
- Los sistemas de administración de fármacos demuestran potencial para mejorar la eficacia del fármaco y la orientación del tumor en el linfoma.
- Estos sistemas pueden mitigar los efectos secundarios, prolongar la circulación y mejorar la penetración de la barrera hematoencefálica.
- Varias plataformas muestran perspectivas prometedoras para el tratamiento dirigido del linfoma.
Conclusiones:
- Los nuevos sistemas de administración de fármacos representan un avance significativo en el tratamiento del linfoma.
- La administración dirigida tiene el potencial de superar las limitaciones terapéuticas actuales y mejorar el pronóstico del paciente.
- Un mayor desarrollo de estos sistemas puede allanar el camino para las terapias de linfoma de próxima generación.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:16Drug Delivery: Overview
422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509